FDA Enforcement Class II Terminated

Proteus 235, Proton Therapy System a medical device designed to produce and delivers a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Recall: Z-0938-2018 · Reported March 21, 2018

Enforcement

Recall Number
Z-0938-2018
Event ID
79230
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Ion Beam Applications S.A.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
March 21, 2018
Initiation Date
November 17, 2017
Classification Date
March 9, 2018
Termination Date
June 14, 2021
Address
Chemin du Cyclotron, 3, Louvain La Neuve, N/A, Belgium

Description

Proteus 235, Proton Therapy System a medical device designed to produce and delivers a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Reason

There is a risk of misalignment of the patient when using treatment plans with multiple isocenters.

Code Info

PAT.000 (US), PAT.001 (CN), PAT.003 (KR), PAT.006 (US), PAT.107 (EU), PAT.108 (US), PAT.109 (US), PAT.110 (US), PAT.111 (EU), PAT.112 (US), PAT.113 (US), PAT.114 (EU), PAT.115 (EU), SAT.116 (US), SAT.117 (EU), SAT.119 (US), SAT.120 (EU), SAT.122 (EU), SAT.123 (US), SAT.126 (US), SAT.132 (EU), SAT.133 (US), SBF.101 (EU), SBF.105 (US)

Distribution

Nationally

Quantity

37